← FDA DRUG APPROVALS
FDA ANDA · ANDA210755
CONCENTRATED IBUPROFEN INFANTS
ibuprofen
Sponsor: GUARDIAN DRUG
APPLICATION
ANDA210755
TYPE
ANDA
ORIGINAL APPROVAL
2018-09-26
LATEST ACTION
2018-09-26
ROUTE
ORAL
DOSAGE FORM
SUSPENSION/DROPS
MARKETING STATUS
Over-the-counter
Products
IBUPROFENOver-the-counter
IBUPROFEN 40MG/ML · SUSPENSION/DROPS · ORAL
Approval history
2018-09-26UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.